Global Autoimmune Disease Diagnostics Market - Products, Disease Types and Test Types
Autoimmune diseases occur when the immune system mistakenly attacks healthy cells, causing inflammation, tissue damage, and organ dysfunction. They can be systemic, affecting multiple organs as in rheumatoid arthritis or lupus, or localized, targeting specific organs such as in type 1 diabetes or celiac disease. Diagnosing these conditions is complex due to overlapping symptoms, requiring a combination of clinical evaluation, patient history, and specialized laboratory testing. Common diagnostic tools include autoantibody detection assays like ANA and RF tests, organ-specific antibody analysis, inflammatory markers such as C-reactive protein and ESR, and imaging or biopsy studies for confirmation. Early and accurate diagnosis is essential for effective disease management and improved patient outcomes. Advances in genomics, proteomics, bioinformatics, and artificial intelligence are transforming the field, enabling more precise, personalized, and predictive diagnostic solutions that enhance clinical decision-making.
The global autoimmune disease diagnostics market is estimated at USD 6.2 billion in 2025 and projected to reach USD 10.2 billion by 2032, registering a CAGR of 7.4% during 2025 to 2032. Growth is driven by the rising prevalence of over 100 autoimmune disorders, including lupus, multiple sclerosis, and rheumatoid arthritis, alongside lifestyle and environmental factors that elevate risk. Growing awareness, government initiatives, and supportive reimbursement policies in developed economies are encouraging early testing. Rapid progress in immunoassays, biomarker research, molecular diagnostics, and next-generation sequencing has improved diagnostic speed and accuracy, while AI-enabled analytics enhance data interpretation. The expansion of point-of-care and at-home testing, supported by microfluidics-based platforms, is improving accessibility across regions. Strengthened healthcare infrastructure in Asia-Pacific, rising global health expenditure, and strategic collaborations between pharmaceutical and diagnostic firms are accelerating innovation. With aging populations, preventive healthcare trends, and the shift toward precision medicine, autoimmune disease diagnostics are becoming central to next-generation healthcare delivery.
Autoimmune Disease Diagnostics Regional Market Analysis
North America accounts for the largest share of the global autoimmune disease diagnostics market, estimated at 41% in 2025, supported by a high disease burden, advanced healthcare systems, favorable reimbursement policies, and strong presence of leading diagnostic companies. The United States anchors this leadership with extensive adoption of ELISA, chemiluminescence, and AI-based diagnostic platforms, complemented by robust R&D investments and broad insurance coverage. In contrast, Asia-Pacific is set to expand the fastest, recording a CAGR of 8.7% from 2025 to 2032, driven by rising prevalence of autoimmune conditions, improved healthcare access, and government-supported screening initiatives. China leads the region with its vast patient base and large-scale diagnostic programs, while India emerges as the fastest-growing market owing to expanding infrastructure, affordable test kits, and greater disease awareness. Japan continues to play a pivotal role in precision diagnostics, particularly for thyroid and celiac disorders, supported by national health programs and its aging population. The region's growth is reinforced by domestic manufacturing incentives, international partnerships, and increasing investments in healthcare innovation.
Autoimmune Disease Diagnostics Market Analysis by Product
Reagents & consumables represent the largest product category in the autoimmune disease diagnostics market, holding 68% of the share in 2025, owing to their recurring demand in high-volume laboratory testing and the increasing use of advanced assay kits for rapid, reliable results. Their continuous consumption in ELISA, immunofluorescence, and multiplex immunoassays, requiring specialized reagents, antibodies, and buffers, sustains this dominance. Expanding diagnostic networks, from hospitals to independent labs, further amplifies demand, while innovations in biomarkers and assay design drive the need for customized, high-precision reagents. Meanwhile, instruments, though smaller in share, are expected to post the fastest growth exceeding 8% CAGR during 2025-2032, driven by technological progress in lab automation, multiplex platforms, and AI-integrated systems enabling high-throughput, accurate, and rapid testing. The growing focus on early detection and automation supports steady instrument adoption, despite higher initial costs and longer replacement cycles.
Autoimmune Disease Diagnostics Market Analysis by Disease Type
Systemic autoimmune diseases lead the market in 2025 with a 63% share and are projected to grow at the fastest CAGR of 7.6% through 2032. Their dominance is attributed to the complexity of multi-organ conditions like rheumatoid arthritis, lupus, and multiple sclerosis that require comprehensive antibody panels and frequent monitoring. Rheumatoid arthritis holds the largest portion within this group at 36.7% in 2025, reflecting its widespread prevalence and the need for early biomarker-based detection through RF and anti-CCP assays. Multiple sclerosis, on the other hand, is emerging as the fastest-growing condition with a 8.3% CAGR, fueled by expanding biomarker research and the emphasis on early intervention to manage progression.
Autoimmune Disease Diagnostics Market Analysis by Test Type
Among test types, Antinuclear Antibody (ANA) tests hold the leading share of 31% in 2025, reflecting their central role in early detection and ongoing monitoring of autoimmune conditions. Their extensive use in hospitals and diagnostic laboratories is reinforced by continuous improvements in ELISA, indirect immunofluorescence, and multiplex assay technologies that enhance accuracy and throughput. Growing disease awareness, expansion of diagnostic facilities, and rising healthcare investment further sustain this segment's strong position. Meanwhile, Autoantibodies & Immunologic Tests are set to record the fastest growth, at 7.8% CAGR between 2025 and 2032, driven by their precision in detecting early-stage autoantibodies, the adoption of multiplexed and AI-assisted platforms, and increasing use in personalized medicine. The need for accurate, rapid, and cost-effective diagnostic solutions continues to fuel robust growth across both ANA and autoantibody testing segments worldwide.
Autoimmune Disease Diagnostics Market Report Scope
This global report on Autoimmune Disease Diagnostics analyzes the market based on product, disease type, and test type. In addition to providing profiles of major companies operating in this space, the latest corporate and industrial developments have been covered to offer a clear panorama of how and where the market is progressing.
Key Metrics
Historical Period: 2022-2024
Base Year: 2025
Forecast Period: 2025-2032
Units: Value market in US$
Companies Mentioned: 15
Autoimmune Disease Diagnostics Market by Geographic Region
The global autoimmune disease diagnostics market is estimated at USD 6.2 billion in 2025 and projected to reach USD 10.2 billion by 2032, registering a CAGR of 7.4% during 2025 to 2032. Growth is driven by the rising prevalence of over 100 autoimmune disorders, including lupus, multiple sclerosis, and rheumatoid arthritis, alongside lifestyle and environmental factors that elevate risk. Growing awareness, government initiatives, and supportive reimbursement policies in developed economies are encouraging early testing. Rapid progress in immunoassays, biomarker research, molecular diagnostics, and next-generation sequencing has improved diagnostic speed and accuracy, while AI-enabled analytics enhance data interpretation. The expansion of point-of-care and at-home testing, supported by microfluidics-based platforms, is improving accessibility across regions. Strengthened healthcare infrastructure in Asia-Pacific, rising global health expenditure, and strategic collaborations between pharmaceutical and diagnostic firms are accelerating innovation. With aging populations, preventive healthcare trends, and the shift toward precision medicine, autoimmune disease diagnostics are becoming central to next-generation healthcare delivery.
Autoimmune Disease Diagnostics Regional Market Analysis
North America accounts for the largest share of the global autoimmune disease diagnostics market, estimated at 41% in 2025, supported by a high disease burden, advanced healthcare systems, favorable reimbursement policies, and strong presence of leading diagnostic companies. The United States anchors this leadership with extensive adoption of ELISA, chemiluminescence, and AI-based diagnostic platforms, complemented by robust R&D investments and broad insurance coverage. In contrast, Asia-Pacific is set to expand the fastest, recording a CAGR of 8.7% from 2025 to 2032, driven by rising prevalence of autoimmune conditions, improved healthcare access, and government-supported screening initiatives. China leads the region with its vast patient base and large-scale diagnostic programs, while India emerges as the fastest-growing market owing to expanding infrastructure, affordable test kits, and greater disease awareness. Japan continues to play a pivotal role in precision diagnostics, particularly for thyroid and celiac disorders, supported by national health programs and its aging population. The region's growth is reinforced by domestic manufacturing incentives, international partnerships, and increasing investments in healthcare innovation.
Autoimmune Disease Diagnostics Market Analysis by Product
Reagents & consumables represent the largest product category in the autoimmune disease diagnostics market, holding 68% of the share in 2025, owing to their recurring demand in high-volume laboratory testing and the increasing use of advanced assay kits for rapid, reliable results. Their continuous consumption in ELISA, immunofluorescence, and multiplex immunoassays, requiring specialized reagents, antibodies, and buffers, sustains this dominance. Expanding diagnostic networks, from hospitals to independent labs, further amplifies demand, while innovations in biomarkers and assay design drive the need for customized, high-precision reagents. Meanwhile, instruments, though smaller in share, are expected to post the fastest growth exceeding 8% CAGR during 2025-2032, driven by technological progress in lab automation, multiplex platforms, and AI-integrated systems enabling high-throughput, accurate, and rapid testing. The growing focus on early detection and automation supports steady instrument adoption, despite higher initial costs and longer replacement cycles.
Autoimmune Disease Diagnostics Market Analysis by Disease Type
Systemic autoimmune diseases lead the market in 2025 with a 63% share and are projected to grow at the fastest CAGR of 7.6% through 2032. Their dominance is attributed to the complexity of multi-organ conditions like rheumatoid arthritis, lupus, and multiple sclerosis that require comprehensive antibody panels and frequent monitoring. Rheumatoid arthritis holds the largest portion within this group at 36.7% in 2025, reflecting its widespread prevalence and the need for early biomarker-based detection through RF and anti-CCP assays. Multiple sclerosis, on the other hand, is emerging as the fastest-growing condition with a 8.3% CAGR, fueled by expanding biomarker research and the emphasis on early intervention to manage progression.
Autoimmune Disease Diagnostics Market Analysis by Test Type
Among test types, Antinuclear Antibody (ANA) tests hold the leading share of 31% in 2025, reflecting their central role in early detection and ongoing monitoring of autoimmune conditions. Their extensive use in hospitals and diagnostic laboratories is reinforced by continuous improvements in ELISA, indirect immunofluorescence, and multiplex assay technologies that enhance accuracy and throughput. Growing disease awareness, expansion of diagnostic facilities, and rising healthcare investment further sustain this segment's strong position. Meanwhile, Autoantibodies & Immunologic Tests are set to record the fastest growth, at 7.8% CAGR between 2025 and 2032, driven by their precision in detecting early-stage autoantibodies, the adoption of multiplexed and AI-assisted platforms, and increasing use in personalized medicine. The need for accurate, rapid, and cost-effective diagnostic solutions continues to fuel robust growth across both ANA and autoantibody testing segments worldwide.
Autoimmune Disease Diagnostics Market Report Scope
This global report on Autoimmune Disease Diagnostics analyzes the market based on product, disease type, and test type. In addition to providing profiles of major companies operating in this space, the latest corporate and industrial developments have been covered to offer a clear panorama of how and where the market is progressing.
Key Metrics
Historical Period: 2022-2024
Base Year: 2025
Forecast Period: 2025-2032
Units: Value market in US$
Companies Mentioned: 15
Autoimmune Disease Diagnostics Market by Geographic Region
- North America (The United States, Canada, and Mexico)
- Europe (Germany, France, the United Kingdom, Italy, Spain, and Rest of Europe)
- Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, and Rest of South America)
- Rest of World
- Reagents & Consumables
- Instruments
- Systemic Autoimmune Diseases
- Rheumatoid Arthritis (RA)
- Multiple Sclerosis (MS)
- Systemic Lupus Erythematosus (SLE)
- Psoriasis
- Other Systemic Autoimmune Diseases (Including Scleroderma, Sjogren's Syndrome, Dermatomyositis, Mixed Connective Tissue Disease, Behcet's Syndrome, Sarcoidosis, Myasthenia Gravis, and others)
- Localized Autoimmune Diseases
- Type 1 Diabetes
- Inflammatory Bowel Disease (IBD)
- Thyroid Disorders
- Other Localized Autoimmune Diseases (Including Idiopathic Thrombocytopenic Purpura (ITP), Celiac Disease, Addison's Disease, Guillain-Barre Syndrome, Autoimmune Hepatitis, Primary Biliary Cirrhosis, and others)
- Antinuclear Antibody (ANA) Tests
- Autoantibodies and Immunologic Tests
- Complete Blood Count (CBC)?
- C-reactive Protein (CRP) Test
- Urinalysis
- Other Tests (Including Molecular Diagnostics, Inflammatory Markers, Point-of-care tests, Imaging diagnostics, and Emerging Tests)
PART A: GLOBAL MARKET PERSPECTIVE
1. INTRODUCTION
Product Outline
Autoimmune Diseases
Types of Autoimmune Diseases
Systemic Autoimmune Diseases
Rheumatoid Arthritis (RA)
Multiple Sclerosis (MS)
Systemic Lupus Erythematosus (SLE)
Psoriasis
Scleroderma
Sjogren's Syndrome
Dermatomyositis
Mixed Connective Tissue Disease (MCTD)
Behcet's Syndrome
Sarcoidosis
Myasthenia Gravis
Organ-specific/Localized Autoimmune Diseases
Type 1 Diabetes
Celiac Disease
Graves Disease
Hashimoto Thyroiditis
Addison Disease
Inflammatory Bowel Disease (IBD)
Idiopathic Thrombocytopenic Purpura (ITP)
Guillain-Barre Syndrome
Autoimmune Hepatitis
Primary Biliary Cirrhosis
Autoimmune Disease Diagnostics
Antinuclear Antibody (ANA) Tests
Enzyme-linked immunosorbent assay (ELISA)
Complete Blood Count (CBC)
Inflammatory Markers
C - reactive Protein (CRP) Test
Rheumatoid Factor
Erythrocyte Sedimentation Rate (ESR)
Urinalysis
Imaging Diagnostics
Emerging Tests
Point-of-care (POC) ANA testing
Flow Cytometry-Based Assays
2. KEY MARKET TRENDS
Artificial Intelligence(AI) Revolutionizing Autoimmune Disease Diagnostics
Rising Global Burden of Multiple Sclerosis Accelerates Demand for Advanced Autoimmune Diagnostics
Next-Generation Biosensors Accelerate Precision in Autoimmune Testing
Immunology and Antigen-Specific Therapies are Reshaping The Autoimmune Disease Diagnostics Landscape
Precision Medicine and Multi-Target Therapies Drive Growth in Autoimmune Diagnostics
3. KEY MARKET PLAYERS
Abbott Laboratories
AESKU.GROUP GmbH
Beckman Coulter, Inc.
bioMerieux SA
Bio-Rad Laboratories, Inc.
EUROIMMUN
F. Hoffmann-La Roche Ltd
Grifols, S.A.
Hemagen Diagnostics, Inc.
Labcorp Holdings Inc.
Quest Diagnostics Incorporated
Siemens Healthineers AG
Thermo Fisher Scientific, Inc.
Trinity Biotech PLC
Werfen, S.A.
4. KEY BUSINESS AND PRODUCT TRENDS
October 2025
Targeted Genomics Unveils CeliacDx Consumer-Initiated Testing Service
Predicta Biosciences Announces $23.4M Series A Funding for Scale up of Novel Diagnostic and Analytics Platform
September 2025
Diasorin Announces Launch of Novel Immunodiagnostic Assay for Grave's Disease
July 2025
Agilus Diagnostics and Sebia Launch Advanced Anti-MCV Antibody Test in India for Early Detection of Rheumatoid Arthritis
June 2025
Breakthrough Blood Test Detects Coeliac Disease in Gluten-Free Individuals
April 2025
Grifols and IBL Forge Strategic Partnership to Develop Advanced Biomarker Panels
May 2025
EUROIMMUN from Revvity Announces Launch of IDS i20 Analytical Random Access Platform
Additional developments included in the main report
5. GLOBAL MARKET OVERVIEW
Global Autoimmune Disease Diagnostics Market Overview by Product Type
Autoimmune Disease Diagnostics Product Type Market Overview by Global Region
Reagents & Consumables
Instruments
Global Autoimmune Disease Diagnostics Market Overview by Disease Type
Global Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Systemic Autoimmune Diseases Diagnostics Market Overview by Global Region
Global Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Localized Autoimmune Diseases Diagnostics Market Overview by Global Region
Global Autoimmune Disease Diagnostics Market Overview by Test Type
Autoimmune Disease Diagnostics Tests Market Overview by Global Region
Antinuclear Antibody (ANA) Tests
Autoantibodies and Immunologic Tests
Complete Blood Count (CBC)
C-reactive Protein (CRP) Test
Urinalysis Tests
Other Diagnostics Tests
PART B: REGIONAL MARKET PERSPECTIVE
REGIONAL MARKET OVERVIEW
6. NORTH AMERICA
Key Market Dynamics Supporting Growth
Market Pattern & Diagnostic Landscape
Strategic Implications for Industry Participants
North American Autoimmune Disease Diagnostics Market Overview by Geographic Region
North American Autoimmune Disease Diagnostics Market Overview by Product Type
North American Autoimmune Disease Diagnostics Market Overview by Disease Type
North American Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
North American Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
North American Autoimmune Disease Diagnostics Market Overview by Test Type
Country-wise Analysis of North American Autoimmune Disease Diagnostics Market
THE UNITED STATES
United States Autoimmune Disease Diagnostics Market Overview by Product Type
United States Autoimmune Disease Diagnostics Market Overview by Disease Type
United States Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
United States Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
United States Autoimmune Disease Diagnostics Market Overview by Test Type
CANADA
Canadian Autoimmune Disease Diagnostics Market Overview by Product Type
Canadian Autoimmune Disease Diagnostics Market Overview by Disease Type
Canadian Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Canadian Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Canadian Autoimmune Disease Diagnostics Market Overview by Test Type
MEXICO
Mexican Autoimmune Disease Diagnostics Market Overview by Product Type
Mexican Autoimmune Disease Diagnostics Market Overview by Disease Type
Mexican Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Mexican Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Mexican Autoimmune Disease Diagnostics Market Overview by Test Type
7. EUROPE
Key Market Dynamics Supporting Growth
Market Pattern & Diagnostic Landscape
Strategic Implications for Industry Participants
European Autoimmune Disease Diagnostics Market Overview by Geographic Region
European Autoimmune Disease Diagnostics Market Overview by Product Type
European Autoimmune Disease Diagnostics Market Overview by Disease Type
European Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
European Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
European Autoimmune Disease Diagnostics Market Overview by Test Type
Country-wise Analysis of European Autoimmune Disease Diagnostics Market
GERMANY
German Autoimmune Disease Diagnostics Market Overview by Product Type
German Autoimmune Disease Diagnostics Market Overview by Disease Type
German Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
German Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
German Autoimmune Disease Diagnostics Market Overview by Test Type
FRANCE
French Autoimmune Disease Diagnostics Market Overview by Product Type
French Autoimmune Disease Diagnostics Market Overview by Disease Type
French Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
French Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
French Autoimmune Disease Diagnostics Market Overview by Test Type
THE UNITED KINGDOM
United Kingdom Autoimmune Disease Diagnostics Market Overview by Product Type
United Kingdom Autoimmune Disease Diagnostics Market Overview by Disease Type
United Kingdom Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
United Kingdom Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
United Kingdom Autoimmune Disease Diagnostics Market Overview by Test Type
ITALY
Italian Autoimmune Disease Diagnostics Market Overview by Product Type
Italian Autoimmune Disease Diagnostics Market Overview by Disease Type
Italian Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Italian Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Italian Autoimmune Disease Diagnostics Market Overview by Test Type
SPAIN
Spanish Autoimmune Disease Diagnostics Market Overview by Product Type
Spanish Autoimmune Disease Diagnostics Market Overview by Disease Type
Spanish Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Spanish Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Spanish Autoimmune Disease Diagnostics Market Overview by Test Type
REST OF EUROPE
Rest of Europe Autoimmune Disease Diagnostics Market Overview by Product Type
Rest of Europe Autoimmune Disease Diagnostics Market Overview by Disease Type
Rest of Europe Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Rest of Europe Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Rest of Europe Autoimmune Disease Diagnostics Market Overview by Test Type
8. ASIA-PACIFIC
Key Market Dynamics Supporting Growth
Overall Market Growth Pattern
Strategic Implications
Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Geographic Region
Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Product Type
Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Disease Type
Asia-Pacific Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Asia-Pacific Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Test Type
Country-wise Analysis of Asia-Pacific Autoimmune Disease Diagnostics Market
JAPAN
Japanese Autoimmune Disease Diagnostics Market Overview by Product Type
Japanese Autoimmune Disease Diagnostics Market Overview by Disease Type
Japanese Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Japanese Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Japanese Autoimmune Disease Diagnostics Market Overview by Test Type
CHINA
Chinese Autoimmune Disease Diagnostics Market Overview by Product Type
Chinese Autoimmune Disease Diagnostics Market Overview by Disease Type
Chinese Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Chinese Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Chinese Autoimmune Disease Diagnostics Market Overview by Test Type
INDIA
Indian Autoimmune Disease Diagnostics Market Overview by Product Type
Indian Autoimmune Disease Diagnostics Market Overview by Disease Type
Indian Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Indian Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Indian Autoimmune Disease Diagnostics Market Overview by Test Type
SOUTH KOREA
South Korean Autoimmune Disease Diagnostics Market Overview by Product Type
South Korean Autoimmune Disease Diagnostics Market Overview by Disease Type
South Korean Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
South Korean Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
South Korean Autoimmune Disease Diagnostics Market Overview by Test Type
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Product Type
Rest of Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Disease Type
Rest of Asia-Pacific Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Rest of Asia-Pacific Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Rest of Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Test Type
9. SOUTH AMERICA
Key Market Dynamics Supporting Growth
Market Pattern & Diagnostic Landscape
Strategic Implications for Industry Participants
South American Autoimmune Disease Diagnostics Market Overview by Geographic Region
South American Autoimmune Disease Diagnostics Market Overview by Product Type
South American Autoimmune Disease Diagnostics Market Overview by Disease Type
South American Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
South American Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
South American Autoimmune Disease Diagnostics Market Overview by Test Type
Country-wise Analysis of South American Autoimmune Disease Diagnostics Market
BRAZIL
Brazilian Autoimmune Disease Diagnostics Market Overview by Product Type
Brazilian Autoimmune Disease Diagnostics Market Overview by Disease Type
Brazilian Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Brazilian Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Brazilian Autoimmune Disease Diagnostics Market Overview by Test Type
ARGENTINA
Argentine Autoimmune Disease Diagnostics Market Overview by Product Type
Argentine Autoimmune Disease Diagnostics Market Overview by Disease Type
Argentine Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Argentine Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Argentine Autoimmune Disease Diagnostics Market Overview by Test Type
REST OF SOUTH AMERICA
Rest of South America Autoimmune Disease Diagnostics Market Overview by Product Type
Rest of South America Autoimmune Disease Diagnostics Market Overview by Disease Type
Rest of South America Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Rest of South America Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Rest of South America Autoimmune Disease Diagnostics Market Overview by Test Type
10. REST OF WORLD
Rest of World Autoimmune Disease Diagnostics Market Overview by Product Type
Rest of World Autoimmune Disease Diagnostics Market Overview by Disease Type
Rest of World Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Rest of World Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Rest of World Autoimmune Disease Diagnostics Market Overview by Test Type
PART C: GUIDE TO THE INDUSTRY
NORTH AMERICA
EUROPE
ASIA-PACIFIC
PART D: ANNEXURE
RESEARCH METHODOLOGY
FEEDBACK
1. INTRODUCTION
Product Outline
Autoimmune Diseases
Types of Autoimmune Diseases
Systemic Autoimmune Diseases
Rheumatoid Arthritis (RA)
Multiple Sclerosis (MS)
Systemic Lupus Erythematosus (SLE)
Psoriasis
Scleroderma
Sjogren's Syndrome
Dermatomyositis
Mixed Connective Tissue Disease (MCTD)
Behcet's Syndrome
Sarcoidosis
Myasthenia Gravis
Organ-specific/Localized Autoimmune Diseases
Type 1 Diabetes
Celiac Disease
Graves Disease
Hashimoto Thyroiditis
Addison Disease
Inflammatory Bowel Disease (IBD)
Idiopathic Thrombocytopenic Purpura (ITP)
Guillain-Barre Syndrome
Autoimmune Hepatitis
Primary Biliary Cirrhosis
Autoimmune Disease Diagnostics
Antinuclear Antibody (ANA) Tests
Enzyme-linked immunosorbent assay (ELISA)
Complete Blood Count (CBC)
Inflammatory Markers
C - reactive Protein (CRP) Test
Rheumatoid Factor
Erythrocyte Sedimentation Rate (ESR)
Urinalysis
Imaging Diagnostics
Emerging Tests
Point-of-care (POC) ANA testing
Flow Cytometry-Based Assays
2. KEY MARKET TRENDS
Artificial Intelligence(AI) Revolutionizing Autoimmune Disease Diagnostics
Rising Global Burden of Multiple Sclerosis Accelerates Demand for Advanced Autoimmune Diagnostics
Next-Generation Biosensors Accelerate Precision in Autoimmune Testing
Immunology and Antigen-Specific Therapies are Reshaping The Autoimmune Disease Diagnostics Landscape
Precision Medicine and Multi-Target Therapies Drive Growth in Autoimmune Diagnostics
3. KEY MARKET PLAYERS
Abbott Laboratories
AESKU.GROUP GmbH
Beckman Coulter, Inc.
bioMerieux SA
Bio-Rad Laboratories, Inc.
EUROIMMUN
F. Hoffmann-La Roche Ltd
Grifols, S.A.
Hemagen Diagnostics, Inc.
Labcorp Holdings Inc.
Quest Diagnostics Incorporated
Siemens Healthineers AG
Thermo Fisher Scientific, Inc.
Trinity Biotech PLC
Werfen, S.A.
4. KEY BUSINESS AND PRODUCT TRENDS
October 2025
Targeted Genomics Unveils CeliacDx Consumer-Initiated Testing Service
Predicta Biosciences Announces $23.4M Series A Funding for Scale up of Novel Diagnostic and Analytics Platform
September 2025
Diasorin Announces Launch of Novel Immunodiagnostic Assay for Grave's Disease
July 2025
Agilus Diagnostics and Sebia Launch Advanced Anti-MCV Antibody Test in India for Early Detection of Rheumatoid Arthritis
June 2025
Breakthrough Blood Test Detects Coeliac Disease in Gluten-Free Individuals
April 2025
Grifols and IBL Forge Strategic Partnership to Develop Advanced Biomarker Panels
May 2025
EUROIMMUN from Revvity Announces Launch of IDS i20 Analytical Random Access Platform
Additional developments included in the main report
5. GLOBAL MARKET OVERVIEW
Global Autoimmune Disease Diagnostics Market Overview by Product Type
Autoimmune Disease Diagnostics Product Type Market Overview by Global Region
Reagents & Consumables
Instruments
Global Autoimmune Disease Diagnostics Market Overview by Disease Type
Global Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Systemic Autoimmune Diseases Diagnostics Market Overview by Global Region
Global Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Localized Autoimmune Diseases Diagnostics Market Overview by Global Region
Global Autoimmune Disease Diagnostics Market Overview by Test Type
Autoimmune Disease Diagnostics Tests Market Overview by Global Region
Antinuclear Antibody (ANA) Tests
Autoantibodies and Immunologic Tests
Complete Blood Count (CBC)
C-reactive Protein (CRP) Test
Urinalysis Tests
Other Diagnostics Tests
PART B: REGIONAL MARKET PERSPECTIVE
REGIONAL MARKET OVERVIEW
6. NORTH AMERICA
Key Market Dynamics Supporting Growth
Market Pattern & Diagnostic Landscape
Strategic Implications for Industry Participants
North American Autoimmune Disease Diagnostics Market Overview by Geographic Region
North American Autoimmune Disease Diagnostics Market Overview by Product Type
North American Autoimmune Disease Diagnostics Market Overview by Disease Type
North American Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
North American Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
North American Autoimmune Disease Diagnostics Market Overview by Test Type
Country-wise Analysis of North American Autoimmune Disease Diagnostics Market
THE UNITED STATES
United States Autoimmune Disease Diagnostics Market Overview by Product Type
United States Autoimmune Disease Diagnostics Market Overview by Disease Type
United States Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
United States Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
United States Autoimmune Disease Diagnostics Market Overview by Test Type
CANADA
Canadian Autoimmune Disease Diagnostics Market Overview by Product Type
Canadian Autoimmune Disease Diagnostics Market Overview by Disease Type
Canadian Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Canadian Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Canadian Autoimmune Disease Diagnostics Market Overview by Test Type
MEXICO
Mexican Autoimmune Disease Diagnostics Market Overview by Product Type
Mexican Autoimmune Disease Diagnostics Market Overview by Disease Type
Mexican Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Mexican Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Mexican Autoimmune Disease Diagnostics Market Overview by Test Type
7. EUROPE
Key Market Dynamics Supporting Growth
Market Pattern & Diagnostic Landscape
Strategic Implications for Industry Participants
European Autoimmune Disease Diagnostics Market Overview by Geographic Region
European Autoimmune Disease Diagnostics Market Overview by Product Type
European Autoimmune Disease Diagnostics Market Overview by Disease Type
European Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
European Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
European Autoimmune Disease Diagnostics Market Overview by Test Type
Country-wise Analysis of European Autoimmune Disease Diagnostics Market
GERMANY
German Autoimmune Disease Diagnostics Market Overview by Product Type
German Autoimmune Disease Diagnostics Market Overview by Disease Type
German Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
German Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
German Autoimmune Disease Diagnostics Market Overview by Test Type
FRANCE
French Autoimmune Disease Diagnostics Market Overview by Product Type
French Autoimmune Disease Diagnostics Market Overview by Disease Type
French Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
French Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
French Autoimmune Disease Diagnostics Market Overview by Test Type
THE UNITED KINGDOM
United Kingdom Autoimmune Disease Diagnostics Market Overview by Product Type
United Kingdom Autoimmune Disease Diagnostics Market Overview by Disease Type
United Kingdom Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
United Kingdom Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
United Kingdom Autoimmune Disease Diagnostics Market Overview by Test Type
ITALY
Italian Autoimmune Disease Diagnostics Market Overview by Product Type
Italian Autoimmune Disease Diagnostics Market Overview by Disease Type
Italian Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Italian Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Italian Autoimmune Disease Diagnostics Market Overview by Test Type
SPAIN
Spanish Autoimmune Disease Diagnostics Market Overview by Product Type
Spanish Autoimmune Disease Diagnostics Market Overview by Disease Type
Spanish Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Spanish Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Spanish Autoimmune Disease Diagnostics Market Overview by Test Type
REST OF EUROPE
Rest of Europe Autoimmune Disease Diagnostics Market Overview by Product Type
Rest of Europe Autoimmune Disease Diagnostics Market Overview by Disease Type
Rest of Europe Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Rest of Europe Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Rest of Europe Autoimmune Disease Diagnostics Market Overview by Test Type
8. ASIA-PACIFIC
Key Market Dynamics Supporting Growth
Overall Market Growth Pattern
Strategic Implications
Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Geographic Region
Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Product Type
Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Disease Type
Asia-Pacific Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Asia-Pacific Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Test Type
Country-wise Analysis of Asia-Pacific Autoimmune Disease Diagnostics Market
JAPAN
Japanese Autoimmune Disease Diagnostics Market Overview by Product Type
Japanese Autoimmune Disease Diagnostics Market Overview by Disease Type
Japanese Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Japanese Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Japanese Autoimmune Disease Diagnostics Market Overview by Test Type
CHINA
Chinese Autoimmune Disease Diagnostics Market Overview by Product Type
Chinese Autoimmune Disease Diagnostics Market Overview by Disease Type
Chinese Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Chinese Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Chinese Autoimmune Disease Diagnostics Market Overview by Test Type
INDIA
Indian Autoimmune Disease Diagnostics Market Overview by Product Type
Indian Autoimmune Disease Diagnostics Market Overview by Disease Type
Indian Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Indian Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Indian Autoimmune Disease Diagnostics Market Overview by Test Type
SOUTH KOREA
South Korean Autoimmune Disease Diagnostics Market Overview by Product Type
South Korean Autoimmune Disease Diagnostics Market Overview by Disease Type
South Korean Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
South Korean Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
South Korean Autoimmune Disease Diagnostics Market Overview by Test Type
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Product Type
Rest of Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Disease Type
Rest of Asia-Pacific Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Rest of Asia-Pacific Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Rest of Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Test Type
9. SOUTH AMERICA
Key Market Dynamics Supporting Growth
Market Pattern & Diagnostic Landscape
Strategic Implications for Industry Participants
South American Autoimmune Disease Diagnostics Market Overview by Geographic Region
South American Autoimmune Disease Diagnostics Market Overview by Product Type
South American Autoimmune Disease Diagnostics Market Overview by Disease Type
South American Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
South American Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
South American Autoimmune Disease Diagnostics Market Overview by Test Type
Country-wise Analysis of South American Autoimmune Disease Diagnostics Market
BRAZIL
Brazilian Autoimmune Disease Diagnostics Market Overview by Product Type
Brazilian Autoimmune Disease Diagnostics Market Overview by Disease Type
Brazilian Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Brazilian Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Brazilian Autoimmune Disease Diagnostics Market Overview by Test Type
ARGENTINA
Argentine Autoimmune Disease Diagnostics Market Overview by Product Type
Argentine Autoimmune Disease Diagnostics Market Overview by Disease Type
Argentine Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Argentine Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Argentine Autoimmune Disease Diagnostics Market Overview by Test Type
REST OF SOUTH AMERICA
Rest of South America Autoimmune Disease Diagnostics Market Overview by Product Type
Rest of South America Autoimmune Disease Diagnostics Market Overview by Disease Type
Rest of South America Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Rest of South America Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Rest of South America Autoimmune Disease Diagnostics Market Overview by Test Type
10. REST OF WORLD
Rest of World Autoimmune Disease Diagnostics Market Overview by Product Type
Rest of World Autoimmune Disease Diagnostics Market Overview by Disease Type
Rest of World Systemic Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Rest of World Localized Autoimmune Diseases Diagnostics Market Overview by Sub-Type
Rest of World Autoimmune Disease Diagnostics Market Overview by Test Type
PART C: GUIDE TO THE INDUSTRY
NORTH AMERICA
EUROPE
ASIA-PACIFIC
PART D: ANNEXURE
RESEARCH METHODOLOGY
FEEDBACK
